HK1220457A1 - 取代聯芳基化合物 - Google Patents

取代聯芳基化合物

Info

Publication number
HK1220457A1
HK1220457A1 HK16108507.1A HK16108507A HK1220457A1 HK 1220457 A1 HK1220457 A1 HK 1220457A1 HK 16108507 A HK16108507 A HK 16108507A HK 1220457 A1 HK1220457 A1 HK 1220457A1
Authority
HK
Hong Kong
Prior art keywords
biaryl compound
substituted biaryl
substituted
compound
biaryl
Prior art date
Application number
HK16108507.1A
Other languages
English (en)
Inventor
柴川信彥
米田健治
勝部哲嗣
神田智子
伊藤幸治
山本喜代志
岩瀨德明
牛山茂
Original Assignee
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries filed Critical Ube Industries
Publication of HK1220457A1 publication Critical patent/HK1220457A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
HK16108507.1A 2013-03-28 2016-07-18 取代聯芳基化合物 HK1220457A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013069363 2013-03-28
JP2013228489 2013-11-01
PCT/JP2014/059301 WO2014157672A1 (ja) 2013-03-28 2014-03-28 置換ビアリール化合物

Publications (1)

Publication Number Publication Date
HK1220457A1 true HK1220457A1 (zh) 2017-05-05

Family

ID=51624629

Family Applications (2)

Application Number Title Priority Date Filing Date
HK16107171.8A HK1219103A1 (zh) 2013-03-28 2016-06-21 取代聯芳基化合物
HK16108507.1A HK1220457A1 (zh) 2013-03-28 2016-07-18 取代聯芳基化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK16107171.8A HK1219103A1 (zh) 2013-03-28 2016-06-21 取代聯芳基化合物

Country Status (15)

Country Link
US (1) US9676720B2 (zh)
EP (1) EP2980075A4 (zh)
JP (1) JPWO2014157672A1 (zh)
KR (1) KR20150135460A (zh)
CN (1) CN105308023A (zh)
AU (1) AU2014244926A1 (zh)
BR (1) BR112015024743A2 (zh)
CA (1) CA2908223A1 (zh)
HK (2) HK1219103A1 (zh)
MX (1) MX2015013848A (zh)
PH (1) PH12015502255A1 (zh)
RU (1) RU2015145989A (zh)
SG (1) SG11201507976YA (zh)
TW (1) TW201527282A (zh)
WO (1) WO2014157672A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10428046B2 (en) 2014-06-10 2019-10-01 Ube Industries, Ltd. N-substituted sulfonamide compound and method for producing same
US10774072B2 (en) 2014-06-10 2020-09-15 Ube Industries, Ltd. Crystal of N-substituted sulfonamide compound
US10519112B2 (en) 2014-06-10 2019-12-31 Ube Industries, Ltd. Method for producing heteroaromatic sulfonamide compound
JP2017206443A (ja) * 2014-09-26 2017-11-24 宇部興産株式会社 置換ビアリール化合物及び他の医薬の組み合わせ
JP2017206445A (ja) * 2014-09-26 2017-11-24 宇部興産株式会社 呼吸器疾患の治療及び／又は予防のための医薬組成物
CN108884047B (zh) * 2016-03-25 2022-03-08 沈阳三生制药有限责任公司 用于合成被芳基或杂芳基取代的5-羟基-1,7-萘啶化合物的中间体及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA59384C2 (uk) 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
UA67754C2 (uk) 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
US20020063763A1 (en) 2000-11-29 2002-05-30 Mantell David Allen Apparatus and method for removing air bubbles from an ink jet printhead
JP2003528106A (ja) 2000-03-22 2003-09-24 メルク フロスト カナダ アンド カンパニー Ｐｔｐ−１ｂ阻害薬としての硫黄置換アリールジフルオロメチルホスホン酸類
EP1481976B1 (en) 2002-03-05 2012-11-07 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
PL378748A1 (pl) 2003-03-04 2006-05-15 Pfizer Products Inc. Zastosowanie selektywnych agonistów receptora EP2 w leczeniu
WO2005080367A1 (en) 2004-02-12 2005-09-01 Pharmagene Laboratories Limited Ep2 receptor agonists
US7858650B2 (en) 2004-10-22 2010-12-28 Ono Pharmaceutical Co., Ltd. Medicinal composition for inhalation
MX2007008410A (es) 2005-01-14 2007-08-21 Hoffmann La Roche Derivados de tiazol-4-carboxamida como antagonistas de receptor de glutamato metabotropico 5-.
WO2007017687A2 (en) 2005-08-09 2007-02-15 Asterand Uk Limited Ep2 receptor agonists
NZ573964A (en) 2006-07-28 2010-11-26 Pfizer Prod Inc isopropyl [3-({[4-(1H-pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)-amino}methyl)phenoxy]acetate, a prostaglandin E2 receptor agonist (EP2), useful in lower intraocular pressure thereby treating glaucoma
UA94953C2 (en) * 2006-07-28 2011-06-25 Пфайзер Продактс Инк. Ep2 agonists
WO2008065500A2 (en) * 2006-11-30 2008-06-05 Pfizer Products Inc. Heteroaryl amides as type i glycine transport inhibitors
EP2078020A4 (en) 2007-04-10 2011-10-19 Sgx Pharmaceuticals Inc HETEROCYCLIC MODULATORS WITH FUSED CYCLES FOR KINASES
LT2264009T (lt) * 2008-03-12 2019-04-25 Ube Industries, Ltd. Piridilaminoacto rūgšties junginys
JP5300033B2 (ja) * 2009-03-30 2013-09-25 宇部興産株式会社 緑内障の治療又は予防のための医薬組成物
WO2011030865A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 置換ベンジル化合物
US20120226036A1 (en) 2009-09-11 2012-09-06 Ube Industries, Ltd. Substituted carbonyl compound
WO2011030873A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 ベンジル化合物
WO2011030872A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 スルホンアミド化合物
WO2011030871A1 (ja) 2009-09-11 2011-03-17 宇部興産株式会社 Ｎ－置換ヘテロアリール化合物
AU2010293406A1 (en) 2009-09-11 2012-05-03 Ube Industries, Ltd. Aniline compounds
WO2011078303A1 (ja) 2009-12-25 2011-06-30 宇部興産株式会社 アミノピリジン化合物
WO2015030250A1 (ja) * 2013-09-02 2015-03-05 宇部興産株式会社 肺疾患の治療及び／又は予防のための医薬組成物

Also Published As

Publication number Publication date
CN105308023A (zh) 2016-02-03
WO2014157672A1 (ja) 2014-10-02
AU2014244926A1 (en) 2015-11-12
HK1219103A1 (zh) 2017-03-24
BR112015024743A2 (pt) 2017-07-18
RU2015145989A (ru) 2017-05-16
EP2980075A4 (en) 2016-08-10
EP2980075A1 (en) 2016-02-03
TW201527282A (zh) 2015-07-16
CA2908223A1 (en) 2014-10-02
JPWO2014157672A1 (ja) 2017-02-16
PH12015502255A1 (en) 2016-02-01
US9676720B2 (en) 2017-06-13
MX2015013848A (es) 2016-03-01
SG11201507976YA (en) 2015-10-29
KR20150135460A (ko) 2015-12-02
US20160060221A1 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
IL249517B (en) A compound that inhibits trk
HK1222393A1 (zh) 新的喹啉取代的化合物
GB201311891D0 (en) Novel compound
GB201307577D0 (en) New compounds
GB201302368D0 (en) Compound
GB201304526D0 (en) New compounds
HK1219100A1 (zh) 吡啶基吡唑並喹啉化合物
HK1219071A1 (zh) 新化合物
HK1220457A1 (zh) 取代聯芳基化合物
EP2947066A4 (en) PHENOXYALKYLAMINVERBINDUNG
GB201307331D0 (en) Compound
GB201408643D0 (en) Compound
GB201322684D0 (en) New compounds
GB201322678D0 (en) New compounds
GB201322672D0 (en) New compounds
GB201322681D0 (en) New compounds
GB201322438D0 (en) Compound
GB201303572D0 (en) New Compound
GB201315772D0 (en) Compound
GB201305945D0 (en) New compounds
GB201305946D0 (en) New compounds
GB201304782D0 (en) New compounds
GB201304773D0 (en) New compounds
GB201304780D0 (en) New compounds
GB201304777D0 (en) New compounds